BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PLN-101095 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PLN-101095\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06270706-2686@assetmemo.bio
DTSTAMP:20261121T005443Z
DTSTART;VALUE=DATE:20300630
DTEND;VALUE=DATE:20300701
SUMMARY:PLN-101095: Phase 1 readout est. (NCT06270706)
DESCRIPTION:PLN-101095\, phase 1.\nStudy: A Phase 1 Study of PLN-101095 in 
 Adults With Advanced or Metastatic Solid Tumors\nEstimated primary complet
 ion: June 2030. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/pln-1
 01095#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/N
 CT06270706
URL:https://assetmemo.bio/drug/pln-101095#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
